Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Human, Mouse (tested or 100% immunogen sequence identity)
Monkey, Rat, Bat, Dog, Hamster, Horse (at least 90% immunogen sequence identity)
Western blot (0.5 - 2 µg/ml)
Specificity and Use
FGR antibody was raised against synthetic peptide C-TSAEPQYQPGDQT from the C-terminus of human FGR (NP_001036194.1; NP_001036212.1; NP_005239.1). Percent identity by BLAST analysis: Human, Gorilla, Gibbon (100%); Monkey, Marmoset, Mouse, Rat, Hamster, Elephant, Panda, Dog, Bat, Horse (92%); Bovine, Rabbit (85%).
LS-E25255 - Lyophilized - 100 µg - $145.00
Immunizing peptide used to generate LS-C54837. Useful for pre-absorption and neutralization of the antibody's antigen binding site.
Human FGR. This antibody is expected to recognise all three reported isoforms (NP_001036194.1; NP_001036212.1; NP_005239.1).
Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors devoid of kinase activity and contributes to the regulation of immune responses, including neutrophil, monocyte, macrophage and mast cell functions, cytoskeleton remodeling in response to extracellular stimuli, phagocytosis, cell adhesion and migration. Promotes mast cell degranulation, release of inflammatory cytokines and IgE-mediated anaphylaxis.